MedTrace Logo

Randomized Trials of Vitamin Supplements and Eye Disease

NCT00000161 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2005-06-24

No results posted yet for this study

Summary

To determine whether vitamin E supplementation reduces the risk of cataract and age-related macular degeneration (AMD) in women.

To determine whether vitamin C supplementation reduces the risk of cataract and AMD in women.

To determine whether beta-carotene supplementation reduces the risk of cataract and AMD in women.

To determine whether alternate day, low-dose aspirin reduces the risk of cataract and AMD in women.

To identify potential risk factors for cataract and AMD including cigarette smoking, alcohol intake, blood pressure, blood cholesterol, cardiovascular disease, height, body mass index, and diabetes.

Conditions

  • Macular Degeneration
  • Cataract

Interventions

DRUG

Aspirin

DRUG

Beta-Carotene

DRUG

Vitamin C

DRUG

Vitamin E

Sponsors & Collaborators

  • National Eye Institute (NEI)

    lead NIH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1993-08-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000161 on ClinicalTrials.gov